Rxreliance

AMYLOID B-PROTEIN (1-16). 0.5mg The Cu2+ complex of this soluble amyloid +-protein fragment showed significant oxidative activities toward the catechol-like substrate 1,2,3-trihydroxylbenzene (pyrogallol) and plasmid DNA cleavage.

AMYLOID B-PROTEIN (1-16). 1mg The Cu2+ complex of this soluble amyloid +-protein fragment showed significant oxidative activities toward the catechol-like substrate 1,2,3-trihydroxylbenzene (pyrogallol) and plasmid DNA cleavage.

AMYLOID B-PROTEIN (35-25). 1mg MLGIIAGKNSG, inactive control. CAS: 147740-73-6 C45H81N13O14S FW: 1060.28 . amyloid

AMYLOID B-PROTEIN (35-25). 5mg MLGIIAGKNSG, inactive control. CAS: 147740-73-6 C45H81N13O14S FW: 1060.28 . amyloid

AMYLOID B-PROTEIN (1-38). 0.5mg Like the amyloid +-protein fragment (25-35) (H-1192), the fragment (1-38) destabilizes calcium homeostasis and renders human cortical neurons vulnerable to environmental insults. CAS: 131438-74-9 C184H277N51O56S FW: 4131.6 . amyloid

AMYLOID B-PROTEIN (1-38). 1mg Like the amyloid +-protein fragment (25-35) (H-1192), the fragment (1-38) destabilizes calcium homeostasis and renders human cortical neurons vulnerable to environmental insults. CAS: 131438-74-9 C184H277N51O56S FW: 4131.6 . amyloid

AMYLOID B-PROTEIN (40-1). 0.5mg Inactive control. CAS: 144409-99-4 C194H295N53O58S FW: 4329.86 . amyloid

AMYLOID B-PROTEIN (40-1). 1mg Inactive control. CAS: 144409-99-4 C194H295N53O58S FW: 4329.86 . amyloid

AMYLOID B-PROTEIN (42-1). 0.5mg Inactive control for A+ 1-42 (H-1386, H-6466). CAS: 317366-82-8 C203H311N55O60S FW: 4514.1 . amyloid

AMYLOID B-PROTEIN (42-1). 1mg Inactive control for A+ 1-42 (H-1386, H-6466). CAS: 317366-82-8 C203H311N55O60S FW: 4514.1 . amyloid

(PYR3)-AMYLOID B-PROTEIN (3-42). 0.5mg (Pyr-)-Amyloid +-Protein (3-42) was found to be the predominant amyloid +-peptide structure deposited in human brain of Alzheimer's disease and Down's syndrome patients. Therefore, (Pyr-)-A+ (3-42) is sug gested to accumulate in the brain and to trigger the formation of insoluble amyloid +-peptide deposits. Nussbaum et al. studies the Prion-like behaviour and tau-dependent cytotoxicity of the truncated A+ sequence. CAS: 183449-57-2 C196H299N53O55S FW: 4309.92 . amyloid

(PYR3)-AMYLOID B-PROTEIN (3-42). 1mg (Pyr-)-Amyloid +-Protein (3-42) was found to be the predominant amyloid +-peptide structure deposited in human brain of Alzheimer's disease and Down's syndrome patients. Therefore, (Pyr-)-A+ (3-42) is sug gested to accumulate in the brain and to trigger the formation of insoluble amyloid +-peptide deposits. Nussbaum et al. studies the Prion-like behaviour and tau-dependent cytotoxicity of the truncated A+ sequence. CAS: 183449-57-2 C196H299N53O55S FW: 4309.92 . amyloid

AMYLOID BRI PROTEIN PRECURSOR277 . 1mg C87H141N21O30S FW: 1993.27 . amyloid

AMYLOID BRI PROTEIN PRECURSOR277 . 5mg C87H141N21O30S FW: 1993.27 . amyloid

ENT-AMYLOID B-PROTEIN (1-42). 0.5mg All-D-A+ (1-42) exhibits similar properites than the all-L A+. The peptide forms ion channels in lipid bilayers. CAS: 342896-25-7 C203H311N55O60S FW: 4514.1 . amyloid

ENT-AMYLOID B-PROTEIN (1-42). 1mg All-D-A+ (1-42) exhibits similar properites than the all-L A+. The peptide forms ion channels in lipid bilayers. CAS: 342896-25-7 C203H311N55O60S FW: 4514.1 . amyloid

AMYLOID B-PROTEIN (1-40). 0.5mg Compared to the TFA salt, the HCl salt of amyloid +-protein (1-40) easily forms +-structures in PBS within a few hours at 25-C. +-structure formation is essential for amyloid peptide toxicity. CAS: 131438-79-4 C194H295N53O58S FW: 4329.86 . amyloid

AMYLOID B-PROTEIN (1-40). 1mg Compared to the TFA salt, the HCl salt of amyloid +-protein (1-40) easily forms +-structures in PBS within a few hours at 25-C. +-structure formation is essential for amyloid peptide toxicity. CAS: 131438-79-4 C194H295N53O58S FW: 4329.86 . amyloid

AMYLOID B-PROTEIN (33-42). 1mg GLMVGGVVIA, a partial sequence of +-amyloid protein which is used for raising antibodies against A+ 1-42. Li et al. studied the aggregation behavior of this and other A+ 1-42 C-terminal fragments. CAS: 178949-81-0 C41H74N10O11S FW: 915.17 . Synonym: Amyloid b/A4 Protein Precursor770 (704-713), APP770 (704-713)

AMYLOID B-PROTEIN (1-40) (MOUSE. 0.5mg CAS: 144409-98-3 C190H291N51O57S FW: 4233.78 . amyloid

AMYLOID B-PROTEIN (1-40) (MOUSE. 1mg CAS: 144409-98-3 C190H291N51O57S FW: 4233.78 . amyloid

BIOTINYL-AMYLOID B-PROTEIN (1-42). 0.5mg Biotinyl-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA. C213H325N57O62S2 FW: 4740.4 . amyloid

BIOTINYL-AMYLOID B-PROTEIN (1-42). 1mg Biotinyl-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA. C213H325N57O62S2 FW: 4740.4 . amyloid

AMYLOID B-PROTEIN (31-35). 1mg The neurotoxicity of the short fragment IIGLM is similar to that of amyloid +-protein (1-42) (H-1368).

AMYLOID B-PROTEIN (31-35). 5mg The neurotoxicity of the short fragment IIGLM is similar to that of amyloid +-protein (1-42) (H-1368).

(MET(O)35)-AMYLOID B-PROTEIN 1-42. 1mg (Met(O)-G)-Amyloid +-protein (1-42) (H-5888), in contrast to A+ 1-42 (H-1368), has been shown to be non-toxic to 9-11 day-old rat embryonic hippocampal neuronal cultures and not to produce any protein oxidation. It has also been demonstrated that fibril formation is not affected by Met(O)-G. For the Nle analog see H-7308. C203H311N55O61S FW: 4530.1 . Synonym: Amyloid b-Protein (1-42) sulfoxide

BIOTINYL-AMYLOID B-PROTEIN (1-40). 0.5mg CAS: 183906-14-1 C204H309N55O60S2 FW: 4556.16 . amyloid

BIOTINYL-AMYLOID B-PROTEIN (1-40). 1mg CAS: 183906-14-1 C204H309N55O60S2 FW: 4556.16 . amyloid

AMYLOID B-PROTEIN (1-42) (MOUSE. 0.5mg CAS: 166090-74-0 C199H307N53O59S FW: 4418.01 . amyloid

AMYLOID B-PROTEIN (1-42) (MOUSE. 1mg CAS: 166090-74-0 C199H307N53O59S FW: 4418.01 . amyloid

AMYLOID B-PROTEIN (1-28). 0.5mg The remarkable histochemical features of Alzheimer's disease (AD) are plaques that contain cores of extracellular filaments, which have been identified as amyloid substance. The major component of this amyloid is the +-protein. The synthetic peptide, having the same sequence as the N-terminal 28 residues, formed fibrils that have the same antigenic and structural features like the native AD amyloid filaments. CAS: 109770-29-8 C145H209N41O46 FW: 3262.5 . Synonym: Alzheimer's Disease b-Protein (SP28)

AMYLOID B-PROTEIN (1-28). 1mg The remarkable histochemical features of Alzheimer's disease (AD) are plaques that contain cores of extracellular filaments, which have been identified as amyloid substance. The major component of this amyloid is the +-protein. The synthetic peptide, having the same sequence as the N-terminal 28 residues, formed fibrils that have the same antigenic and structural features like the native AD amyloid filaments. CAS: 109770-29-8 C145H209N41O46 FW: 3262.5 . Synonym: Alzheimer's Disease b-Protein (SP28)

AMYLOID B-PROTEIN (12-28). 1mg Injection of the amyloid +-protein fragment VHHQKLVFFAEDVGSNK into different limbic system structures in mice impaired retention with remarkably similar efficacy and in a dose-dependent manner. It is sug gested that this peptide and other amyloid +-protein fragments may exert dysregulatory cognitive effects by incoordination of K+ channel function in neurons, glia and endothelial cells. CAS: 107015-83-8 C89H135N25O25 FW: 1955.2 . Synonym: Alzheimer's Disease b-Protein (12-28)

AMYLOID B-PROTEIN (12-28). 5mg Injection of the amyloid +-protein fragment VHHQKLVFFAEDVGSNK into different limbic system structures in mice impaired retention with remarkably similar efficacy and in a dose-dependent manner. It is sug gested that this peptide and other amyloid +-protein fragments may exert dysregulatory cognitive effects by incoordination of K+ channel function in neurons, glia and endothelial cells. CAS: 107015-83-8 C89H135N25O25 FW: 1955.2 . Synonym: Alzheimer's Disease b-Protein (12-28)

Mca-(Asn670,Leu671)-Amyloidbeta/A4ProteinPrecursor770(667-675)-Lys(Dnp)Mca-Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Lys(Dnp)-OH. Mca-(Asn670,Leu671)-APP770 (667-675)-Lys(Dnp).